Skip to main content
Fig. 14 | Harm Reduction Journal

Fig. 14

From: Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis

Fig. 14

Trend of HCV Ab prevalence among PWID in Iran by recruitment setting. a Trend of HCV Ab prevalence among PWID in the prison setting, the Cochran–Armitage test, P value = 0.17. b Trend of HCV Ab prevalence among PWID in the hospital/healthcare center setting, the Cochran–Armitage test, P value < 0.001. c Trend of HCV Ab prevalence among PWID in the DIC setting, the Cochran–Armitage test, P value = 0.01

Back to article page

Harm Reduction Journal

ISSN: 1477-7517